PHARMA HOLDINGS AS
Operating
Utvikling, markedsføring og salg av medisinske, kjemiske og
bioteknologiske produkter, samt dertil hørende virksomhet. Selskapet
kan ha eierinteresser i foretak innen samme eller tilstøtende
bransjer.
Organization
- CEO
- CG
- Chairman of the board
- BE
Bernt Endrerud1955
- Years since formation
- 10 years
- since Nov 4, 2016
- Type
- Limited company
- VAT registered
- Yes
- Number of employees
- 5
Ownership
- Number of shares and share classes
- 1,353,505
- 1 share class
- Total number of shareholders
- 288
- 151 companies, 137 persons
Financials
- Total operating income 2025
- 2,889,281
- NOK
- Annual total result 2025
- -15,783,124
- NOK
- Total equity 2025
- 14,055,041
- NOK
Last update: Oct 5, 2026
Management
Management / administration
| Name | Role | Shares |
|---|---|---|
CG | Managing Director/CEO | - |
Board
| Name | Role | Shares |
|---|---|---|
BE 1955 | Chairman | - |
HS | Board Member | - |
| Board Member | - | |
| Board Member | - |
Others
| Name | Role | Shares |
|---|---|---|
| Auditor | - | |
| Accountant | - |
Top 10 individual shareholders
| Name | Role | Shares |
|---|---|---|
EB 1955 | - | 40.72 % indirectly |
VB | - | 4.86 % indirectly |
| - | 3.55 % indirectly | |
FJ | - | 3.54 % indirectly |
IR | - | 2.76 % indirectly |
| - | 2.74 % indirectly | |
GL | - | 1.48 % directly |
ET | - | 1.46 % indirectly |
AN | - | 1.46 % indirectly |
AB 1982 | - | 1.11 % indirectly |
Last update: Oct 5, 2026
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
| Ordinary shares | 546,097 | 40.35 % | |
| Ordinary shares | 152,794 | 11.29 % | |
| Ordinary shares | 95,928 | 7.09 % | |
| Ordinary shares | 81,500 | 6.02 % | |
| Ordinary shares | 74,622 | 5.51 % | |
| Ordinary shares | 70,731 | 5.23 % | |
| Ordinary shares | 65,359 | 4.83 % | |
| Ordinary shares | 37,107 | 2.74 % | |
GL | Ordinary shares | 20,000 | 1.48 % |
| Ordinary shares | 13,641 | 1.01 % | |
| Ordinary shares | 13,000 | 0.96 % | |
| Ordinary shares | 12,965 | 0.96 % | |
HV | Ordinary shares | 12,500 | 0.92 % |
T Closed | Ordinary shares | 12,500 | 0.92 % |
KS | Ordinary shares | 12,159 | 0.9 % |
| Ordinary shares | 12,107 | 0.89 % | |
| Ordinary shares | 10,015 | 0.74 % | |
| Ordinary shares | 10,010 | 0.74 % | |
| Ordinary shares | 10,000 | 0.74 % | |
| Ordinary shares | 8,807 | 0.65 % | |
| Ordinary shares | 7,861 | 0.58 % | |
| Ordinary shares | 6,992 | 0.52 % | |
| Ordinary shares | 4,950 | 0.37 % | |
| Ordinary shares | 4,047 | 0.3 % | |
| Ordinary shares | 3,000 | 0.22 % | |
ES | Ordinary shares | 3,000 | 0.22 % |
| Ordinary shares | 2,381 | 0.18 % | |
| Ordinary shares | 2,297 | 0.17 % | |
| Ordinary shares | 1,808 | 0.13 % | |
| Ordinary shares | 1,760 | 0.13 % | |
| Ordinary shares | 1,722 | 0.13 % | |
| Ordinary shares | 1,715 | 0.13 % | |
BK 1948 | Ordinary shares | 1,614 | 0.12 % |
SB | Ordinary shares | 1,515 | 0.11 % |
| Ordinary shares | 1,511 | 0.11 % | |
RØ 1962 | Ordinary shares | 1,340 | 0.1 % |
| Ordinary shares | 1,220 | 0.09 % | |
| Ordinary shares | 1,143 | 0.08 % | |
| Ordinary shares | 1,059 | 0.08 % | |
| Ordinary shares | 1,016 | 0.08 % | |
| Ordinary shares | 1,000 | 0.07 % | |
| Ordinary shares | 917 | 0.07 % | |
| Ordinary shares | 767 | 0.06 % | |
| Ordinary shares | 767 | 0.06 % | |
| Ordinary shares | 618 | 0.05 % | |
| Ordinary shares | 617 | 0.05 % | |
| Ordinary shares | 605 | 0.04 % | |
| Ordinary shares | 588 | 0.04 % | |
SG 1954 | Ordinary shares | 553 | 0.04 % |
| Ordinary shares | 534 | 0.04 % | |
| Ordinary shares | 518 | 0.04 % | |
| Ordinary shares | 503 | 0.04 % | |
| Ordinary shares | 490 | 0.04 % | |
| Ordinary shares | 484 | 0.04 % | |
| Ordinary shares | 476 | 0.04 % | |
| Ordinary shares | 426 | 0.03 % | |
| Ordinary shares | 406 | 0.03 % | |
| Ordinary shares | 377 | 0.03 % | |
| Ordinary shares | 361 | 0.03 % | |
| Ordinary shares | 335 | 0.02 % | |
| Ordinary shares | 335 | 0.02 % | |
| Ordinary shares | 325 | 0.02 % | |
KH | Ordinary shares | 314 | 0.02 % |
SV 1954 | Ordinary shares | 308 | 0.02 % |
| Ordinary shares | 305 | 0.02 % | |
| Ordinary shares | 305 | 0.02 % | |
IT 1968 | Ordinary shares | 300 | 0.02 % |
HL | Ordinary shares | 300 | 0.02 % |
| Ordinary shares | 290 | 0.02 % | |
| Ordinary shares | 290 | 0.02 % | |
EW 1956 | Ordinary shares | 290 | 0.02 % |
| Ordinary shares | 284 | 0.02 % | |
| Ordinary shares | 280 | 0.02 % | |
MS | Ordinary shares | 235 | 0.02 % |
| Ordinary shares | 228 | 0.02 % | |
| Ordinary shares | 228 | 0.02 % | |
| Ordinary shares | 221 | 0.02 % | |
| Ordinary shares | 217 | 0.02 % | |
SK | Ordinary shares | 217 | 0.02 % |
| Ordinary shares | 210 | 0.02 % | |
| Ordinary shares | 204 | 0.02 % | |
HB 1964 | Ordinary shares | 203 | < 0.01 % |
| Ordinary shares | 203 | < 0.01 % | |
| Ordinary shares | 203 | < 0.01 % | |
EE | Ordinary shares | 199 | < 0.01 % |
| Ordinary shares | 198 | < 0.01 % | |
| Ordinary shares | 194 | < 0.01 % | |
| Ordinary shares | 190 | < 0.01 % | |
FK 1962 | Ordinary shares | 189 | < 0.01 % |
JT 1993 | Ordinary shares | 188 | < 0.01 % |
| Ordinary shares | 183 | < 0.01 % | |
| Ordinary shares | 183 | < 0.01 % | |
| Ordinary shares | 178 | < 0.01 % | |
| Ordinary shares | 169 | < 0.01 % | |
| Ordinary shares | 169 | < 0.01 % | |
| Ordinary shares | 169 | < 0.01 % | |
| Ordinary shares | 168 | < 0.01 % | |
| Ordinary shares | 167 | < 0.01 % | |
| Ordinary shares | 167 | < 0.01 % | |
| Ordinary shares | 166 | < 0.01 % |
Shares owned by the PHARMA HOLDINGS AS
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
| Ordinary shares | 5 | 50 % | |
| Ordinary shares | 68,142 | 2.11 % |
Last update: Sep 25, 2026
Financials
in NOK
Summary
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total operating income | 2,889,281 | 120,000 | 1,740,889 | 4,644,278 | 6,618,124 |
Annual Total Result | -15,783,124 | -17,595,202 | -15,173,542 | -27,057,210 | -13,746,133 |
Total assets | 15,641,095 | 9,497,318 | 21,132,878 | 18,047,424 | 7,077,037 |
Total liabilities | 1,586,054 | 1,339,240 | 4,779,598 | 2,620,602 | 896,773 |
Total equity | 14,055,041 | 8,158,078 | 16,353,280 | 15,426,822 | 6,180,265 |
P&L
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total operating income | 2,889,281 | 120,000 | 1,740,889 | 4,644,278 | 6,618,124 |
Total operating costs | 18,475,307 | 17,912,705 | 16,822,624 | 30,359,079 | 20,393,789 |
Operating result | -15,586,026 | -17,792,705 | -15,081,735 | -25,714,801 | -13,775,665 |
Financial income/costs | -197,098 | 197,504 | -91,808 | -1,342,409 | 29,532 |
Profit before tax | -15,783,124 | -17,595,202 | -15,173,542 | -27,057,210 | -13,746,133 |
Total tax & extraordinary income/cost | 0 | 0 | 0 | 0 | 0 |
Annual Total Result | -15,783,124 | -17,595,202 | -15,173,542 | -27,057,210 | -13,746,133 |
Balance overview
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total fixed assets | 5,570,983 | 6,491,302 | 6,491,302 | 1,258,519 | 1,258,519 |
Total current assets | 10,070,112 | 3,006,016 | 14,641,576 | 16,788,905 | 5,818,518 |
Total assets | 15,641,095 | 9,497,318 | 21,132,878 | 18,047,424 | 7,077,037 |
Short term debt | 1,483,599 | 1,236,785 | 4,677,143 | 2,518,147 | 896,773 |
Long term debt | 102,455 | 102,455 | 102,455 | 102,455 | 0 |
Total liabilities | 1,586,054 | 1,339,240 | 4,779,598 | 2,620,602 | 896,773 |
Contributed capital | 14,463,019 | 8,158,078 | 16,353,280 | 36,874,476 | 6,180,265 |
Retained earnings | -407,978 | 0 | 0 | -21,447,654 | 0 |
Total equity | 14,055,041 | 8,158,078 | 16,353,280 | 15,426,822 | 6,180,265 |
Total equity and liabilities | 15,641,095 | 9,497,318 | 21,132,878 | 18,047,424 | 7,077,037 |
Classification
21st company classification
BETA
Scaleup
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification